Related Experiment Video
Updated: Jul 12, 2025
A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
Microglia-mediated demyelination protects against CD8+ T cell-driven axon degeneration in mice carrying PLP defects
Janos Groh1,2, Tassnim Abdelwahab3, Yogita Kattimani3
1Department of Neurology, Section of Developmental Neurobiology, University Hospital Würzburg, Würzburg, Germany. janos.groh@tum.de.
Abstract:
Axon degeneration and functional decline in myelin diseases are often attributed to loss of myelin but their relation is not fully understood. Perturbed myelinating glia can instigate chronic neuroinflammation and contribute to demyelination and axonal damage. Here we study mice with distinct defects in the proteolipid protein 1 gene that develop axonal damage which is driven by cytotoxic T cells targeting myelinating oligodendrocytes. We show that persistent ensheathment with perturbed myelin poses a risk for axon degeneration, neuron loss, and behavioral decline. We demonstrate that CD8+ T cell-driven axonal damage is less likely to progress towards degeneration when axons are efficiently demyelinated by activated microglia. Mechanistically, we show that cytotoxic T cell effector molecules induce cytoskeletal alterations within myelinating glia and aberrant actomyosin constriction of axons at paranodal domains. Our study identifies detrimental axon-glia-immune interactions which promote neurodegeneration and possible therapeutic targets for disorders associated with myelin defects and neuroinflammation.
Insights
Myelin defects trigger cytotoxic T cells to damage axons, leading to neurodegeneration. Efficient microglial demyelination can protect axons from this T cell-mediated damage, revealing key interactions in myelin diseases.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Myelin diseases cause axon degeneration and functional decline, but the precise relationship between myelin loss and axonal damage is unclear.
- Myelinating glia, when perturbed, can promote chronic neuroinflammation, demyelination, and axonal injury.
Purpose of the Study:
- To investigate the mechanisms by which defects in the proteolipid protein 1 gene lead to axonal damage.
- To elucidate the role of cytotoxic T cells and glial interactions in myelin-related neurodegeneration.
Main Methods:
- Utilized mouse models with specific proteolipid protein 1 gene defects.
- Investigated the involvement of cytotoxic T cells (CD8+ T cells) and microglia in axonal damage and myelin pathology.
- Analyzed molecular mechanisms including cytoskeletal alterations and actomyosin constriction.
Main Results:
- Axonal damage driven by cytotoxic T cells targeting oligodendrocytes was observed in mice with proteolipid protein 1 gene defects.
- Persistent ensheathment by perturbed myelin increased the risk of axon degeneration, neuron loss, and behavioral decline.
- Efficient demyelination by activated microglia mitigated CD8+ T cell-driven axonal damage.
- Cytotoxic T cell effector molecules were found to induce cytoskeletal changes in myelinating glia and aberrant axonal constriction.
Conclusions:
- Detrimental interactions between axons, glia, and the immune system drive neurodegeneration in myelin disorders.
- Targeting these axon-glia-immune interactions may offer therapeutic strategies for myelin defects and associated neuroinflammation.
